FDA Drug Application (091265) for OLANZAPINE by APOTEX INC

Back to FDA Applications sponsored by APOTEX INC

Application Number091265
Product Number001
FormTABLET, ORALLY DISINTEGRATING;ORAL
Dosage5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameOLANZAPINE
Active IngredientOLANZAPINE

Active IngredientCount
List of drugs with Active Ingredient OLANZAPINE5


Back to FDA Applications sponsored by APOTEX INC